JT
NVAX icon

Jupiter Topco’s Novavax NVAX Stock Holding History

Jupiter Topco’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$573K Buy
+60,815
New +$545K ﹤0.01% 2040

Other funds holding NVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jupiter Topco's NVAX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Novavax (NVAX) in Q2 2026: 60,815 shares worth $573K. The stake represents ﹤0.01% of the portfolio and ranks #2040 among its holdings.

247 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Jupiter Topco held 60,815 shares of Novavax worth $573K as of Q2 2026.
  • Novavax was a new Jupiter Topco position in Q2 2026.
  • Novavax made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #2040 holding.
  • 247 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.